Patent · US Active

Compositions and methods for the treatment of contact lens discomfort

US12083147B2 · kind B2 · utility

0Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2022
Grant dateSep 10, 2024
Priority date
Expiry dateApr 18, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG02C7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are compositions and methods for the treatment of contact lens discomfort (CLD) and/or lid wiper epitheliopathy (LWE). Such compositions comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of such compositions to the inner surface of the eyelid provides therapeutic benefit to patients suffering from contact lens discomfort (CLD) and/or lid wiper epitheliopathy (LWE).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.